IL6 and COVID-19: Similarly, female patients with acute COVID-19 also exhibited high levels of circulating IL-6 (127.64 ± 22.24 pg/mL) upon admission, which significantly decreased following the administration of 1α,25(OH)2D3 (1.84 ± 0.77 pg/mL) [47].